[
    [
        {
            "time": "2018-03-15",
            "original_text": "AbbVie says it will appeal $448 million antitrust judgment",
            "features": {
                "keywords": [
                    "AbbVie",
                    "antitrust",
                    "judgment",
                    "appeal"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie says it will appeal $448 million antitrust judgment",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "AbbVie, AndroGel Partner Owe $448 Mln In FTC Antitrust Case",
            "features": {
                "keywords": [
                    "AbbVie",
                    "AndroGel",
                    "FTC",
                    "antitrust",
                    "case"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie, AndroGel Partner Owe $448 Mln In FTC Antitrust Case",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge",
            "features": {
                "keywords": [
                    "AbbVie",
                    "AndroGel",
                    "antitrust",
                    "U.S. judge"
                ],
                "sentiment_score": -0.65,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "AbbVie, AndroGel partner owe $488 million in antitrust case: U.S. judge",
            "features": {
                "keywords": [
                    "AbbVie",
                    "AndroGel",
                    "antitrust",
                    "U.S. judge"
                ],
                "sentiment_score": -0.65,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie, AndroGel partner owe $488 million in antitrust case: U.S. judge",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]